Luteoma

An ovarian neoplasm composed of LUTEAL CELLS derived from luteinized GRANULOSA CELLS and THECA CELLS. Luteomas respond to GONADOTROPINS, and vary in their hormone production (PROGESTERONE; ESTROGENS; or ANDROGENS). During PREGNANCY, a transient type of luteoma may develop due to an exaggerated LUTEINIZATION of the OVARY.

Also Known As:

Gestational Luteoma; Luteinoma; Luteoma of Pregnancy; Gestational Luteomas; Luteoma, Gestational; Luteoma, Pregnancy; Luteomas; Luteomas, Gestational; Luteomas, Pregnancy; Pregnancy Luteomas; Pregnancy Luteoma

Neoplasms: 1361496
- Neoplasms by Site: 4
  - Endocrine Gland Neoplasms: 135
    - Ovarian Neoplasms: 40434
      - Luteoma: 88
- Neoplasms by Histologic Type: 2
  - Gonadal Tissue Neoplasms
    - Sex Cord-Gonadal Stromal Tumors: 237
      - Luteoma: 88
Urogenital Diseases: 129
- Urogenital Neoplasms: 488
  - Female Genital Neoplasms: 106
    - Ovarian Neoplasms: 40434
      - Luteoma: 88
- Genital Diseases: 114
  - Female Genital Diseases: 400
    - Adnexal Diseases: 60
      - Ovarian Diseases: 676
        Ovarian Neoplasms: 40434
        Luteoma: 88
- Female Urogenital Diseases and Pregnancy Complications
  - Female Urogenital Diseases
    - Urogenital Neoplasms: 488
      - Female Genital Neoplasms: 106
        Ovarian Neoplasms: 40434
        Luteoma: 88
    - Female Genital Diseases: 400
      - Adnexal Diseases: 60
        Ovarian Diseases: 676
        Ovarian Neoplasms: 40434
        Luteoma: 88
Endocrine System Diseases: 996
- Endocrine Gland Neoplasms: 135
  - Ovarian Neoplasms: 40434
    - Luteoma: 88
- Gonadal Disorders: 30
  - Ovarian Diseases: 676
    - Ovarian Neoplasms: 40434
      - Luteoma: 88

M Pancaldi Selected Research

M Pancaldi Research Topics

Disease

Drug/Important Bio-Agent (IBA)